The underlying cellular mechanism in the effect of tetramethylpyrazine on the anion secretion of colonic mucosa

Jpn J Physiol. 2005 Dec;55(6):325-9. doi: 10.2170/jjphysiol.RP000905. Epub 2005 Dec 8.

Abstract

The present study investigated the underlying cellular mechanism in the effect of ligustrazine (tetramethylpyrazine, TMP) on the anion secretion of colonic mucosa in rats using a short-circuit current (I(sc)) technique in conjunction with "tool drugs." (i) After a pretreatment of the tissues by bathing the bilateral surface with Cl(-)-free Krebs-Henseleit (K-H) solution for over an hour, a basolateral application of 1 mmol/l TMP produced an increase in I(sc), and the total charges transported for 30 min were about 8.7 +/- 1.4 mC/cm(2); an apical pretreatment of DPC and a basolateral addition of acetazolamide decreased the TMP-induced I(sc) by about 60% (P < 0.01) and 45% (P < 0.05), respectively; a basolateral application of 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), the inhibitor of Na(+)-HCO(3)(-) cotransporter (NBC), did not alter the TMP-induced I(sc). (ii) After the bilateral surface of mucosa was bathed with HCO(3)(-)-free K-H solution for over an hour, a basolateral application of 1 mmol/l TMP produced an increase in I(sc), and the total charges transported in 30 min were about 8.3 +/- 1.9 mC/cm(2); an apical pretreatment of DPC (1 mmol/l), the inhibitor of Cl(-) channels, decreased the TMP-induced Isc by about 84% (P < 0.01). The basolateral presence of bumetanide (0.1 mmol/l), the inhibitor of Na(+)-K(+)-Cl(-) cotransporter (NKCC), significantly reduced the TMP-evoked I(sc) by about 86% (P < 0.01). In conclusion, (i) ligustrazine could promote colonic mucosa secretion Cl(-) via apical Cl(-) channels and basolateral NKCC; (ii) ligustrazine could promote colonic mucosa secretion HCO(3)(-) via apical Cl(-) channels and the basolateral diffusion of CO(2).

MeSH terms

  • 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid / pharmacology
  • Acetazolamide / pharmacology
  • Animals
  • Bicarbonates / metabolism
  • Bumetanide / pharmacology
  • Calcium Channel Blockers / pharmacology*
  • Carbon Dioxide / metabolism
  • Chloride Channels / antagonists & inhibitors
  • Chloride Channels / drug effects
  • Chloride Channels / physiology
  • Chlorides / metabolism*
  • Colon / cytology
  • Colon / drug effects
  • Colon / metabolism*
  • Cystic Fibrosis Transmembrane Conductance Regulator / physiology
  • Electric Stimulation
  • Intestinal Mucosa / cytology
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / metabolism*
  • Male
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Patch-Clamp Techniques
  • Pyrazines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Bicarbonate Symporters / antagonists & inhibitors
  • Sodium-Potassium-Chloride Symporters / drug effects
  • Sodium-Potassium-Chloride Symporters / physiology
  • ortho-Aminobenzoates / pharmacology

Substances

  • Bicarbonates
  • Calcium Channel Blockers
  • Chloride Channels
  • Chlorides
  • Pyrazines
  • Sodium Potassium Chloride Symporter Inhibitors
  • Sodium-Bicarbonate Symporters
  • Sodium-Potassium-Chloride Symporters
  • ortho-Aminobenzoates
  • Bumetanide
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Carbon Dioxide
  • fenamic acid
  • Acetazolamide
  • 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
  • tetramethylpyrazine